21688 results

Vinayak Vadgaonkar

Bahrain

PCR: a home for everyone in the field of interventional cardiology

12 Oct 2025

In July 2025, a unilateral decision of the ESC closed a chapter on nearly two decades of successful collaboration between ESC-EAPCI and PCR-Europa - a partnership first established in 2006 and most recently renewed in 2023. 

PCR Gulf Valves - Relive the Best of the Course

From opening to closing, explore the best of #PCRGulfValves. Watch videos, discover key figures, access replays and your certificates, and more to keep on learning!

PCR Gulf Valves 2025: useful information about the Course

PCR Tricuspid Focus Group - Referral Meeting in Graz

30 Jul 2025

Join your peers for this meeting on 25-26 September 2025 in Graz, Austria!

Tiago Bignoto

Sao Paulo, Brazil

Fernanda Mangione

Brazil

How will the new valvular guidelines impact my tricuspid programme?

16 Oct 2025

Watch this replay with F. Maisano, J. Dreyfus, J. Hausleiter and M. Sitges to get familiar with new recommendations regarding the treatment of the tricuspid valve and so much more!

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

01 Aug 2025

DOUBLE-CHOICE: Anesthesia strategies and self-expanding valve types for TAVI

29 Aug 2025

Fresh from his DOUBLE-CHOICE trial presentation at ESC Congress 2025 in Madrid, Mohamed Abdel-Wahab joins Yohei Ohno to discuss the key takeaways.

This two-by-two factorial randomised trial in patients undergoing TAVI compared a minimalist strategy using only local anesthesia with the standard of care, as well as two...

Author

Yohei Ohno

Author

Mohamed Abdel-Wahab

The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation

01 Sep 2025

Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.

Author

Chiara De Biase

Duration of DAPT in ACS: The DUAL-ACS Trial

31 Aug 2025

Ali Nazmi Calik interviews David Newby on the landmark DUAL-ACS trial results he presented at ESC Congress 2025 in Madrid.

The trial compared 3 months versus 12 months of dual antiplatelet therapy (DAPT) after myocardial infarction in an all-comer population. Findings suggest that shorter therapy may offer better...

Author

Ali Nazmi Calik

Author

David Newby

OPTION-STEMI: Immediate versus staged complete revascularisation during index admission in patients with STEMI and multivessel disease

02 Sep 2025

Mirvat Alasnag provides her take on OPTION-STEMI, presented by Youngkeun Ahn at ESC Congress 2025 in Madrid.

Author

Mirvat Alasnag

NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome

02 Sep 2025

Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...

Author

Daniele Giacoppo

TAILORED-CHIP: Tailored antiplatelet therapy for complex high-risk PCI

29 Aug 2025

Nicola Ryan provides her take on the results of TAILORED-CHIP presented by Duk-Woo Park at the ESC Congress 2025 in Madrid.

Author

Nicola Ryan

TARGET-FIRST: Early aspirin discontinuation after PCI in low-risk acute MI patients

01 Sep 2025

Elad Asher provides his take on the results of TARGET-FIRST presented by Giuseppe Tarantini at the ESC Congress 2025 in Madrid.

Author

Elad Asher

DAPT-SHOCK-AMI trial: Cangrelor in cardiogenic shock

03 Sep 2025

Kalaivani Mahadevan and Fizzah Choudry provide their take on DAPT-SHOCK-MI presented by Zuzana Motovska at ESC Congress 2025 in Madrid.

Author

Fizzah Choudry

Author

Kalaivani Mahadevan

PCR Mitral Focus Group

19 Aug 2025

Promoting innovation and aligning care in mitral valve disease

TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

03 Sep 2025

Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.

Author

Aaysha Cader

TOP-CABG: the timing of platelet inhibition after coronary artery bypass grafting trial

02 Sep 2025

Jonathan Curio provides his take on TOP-CABG, presented by Xin Yuan at ESC Congress 2025 in Madrid.

Author

Jonathan Curio